Patents by Inventor Roger McNichols
Roger McNichols has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20070219544Abstract: In one embodiment, the disclosure is directed to an integrated apparatus for delivering energy to a tissue. The integrated apparatus included a housing having a distal end and a tubular structure located within the housing forming a first annulus between the tubular structure and the housing. The tubular structure is configured to accept an energy delivery component and is configured to form a second annulus between the tubular structure and the energy delivery component. The first annulus and the second annulus are configured to communicate with each other proximate to the distal end of the housing.Type: ApplicationFiled: May 17, 2007Publication date: September 20, 2007Applicant: VISUALASE, INC.Inventors: Ashok Gowda, Roger McNichols, Marc Gelnett, Matthew Fox
-
Patent number: 7270656Abstract: In one embodiment, the disclosure is directed to an integrated apparatus for delivering energy to a tissue. The integrated apparatus included a housing having a distal end and a tubular structure located within the housing forming a first annulus between the tubular structure and the housing. The tubular structure is configured to accept an energy delivery component and is configured to form a second annulus between the tubular structure and the energy delivery component. The first annulus and the second annulus are configured to communicate with each other proximate to the distal end of the housing.Type: GrantFiled: November 7, 2003Date of Patent: September 18, 2007Assignee: Visualase, Inc.Inventors: Ashok Gowda, Roger McNichols, Marc Gelnett, Matthew Fox
-
Patent number: 7236812Abstract: There are many inventions described and illustrated herein. In one aspect, the present invention is a system, a device and a method for sensing the concentration of an analyte in a fluid (for example, a fluid sample) or matrix. The analyte may be glucose or other chemical of interest. The fluid or matrix may be, for example, the fluid or matrix in the body of an animal (for example, human), or any other suitable fluid or matrix in which it is desired to know the concentration of an analyte. In one embodiment, the invention is a system and/or device that includes one or more layers having a plurality of analyte-equivalents and mobile or fixed receptor molecules with specific binding sites for the analyte-equivalents and analytes under analysis (for example, glucose). The receptor molecules, when exposed to or in the presence of analyte (that resides, for example, in a fluid in an animal), bind with the analyte (or vice versa).Type: GrantFiled: August 27, 2004Date of Patent: June 26, 2007Assignee: BioTex, Inc.Inventors: Ralph Ballerstadt, Roger McNichols, Ashok Gowda
-
Patent number: 7226414Abstract: In one aspect, the present invention is directed to a glucose sensing device for implantation within subcutaneous tissue of an animal body. In one embodiment, the glucose sensing device includes a first chamber containing first magnetic particles and a hydrocolloid solution (for example, ConA-dextran hydrocolloid) wherein the first magnetic particles are dispersed in the hydrocolloid solution. In operation, glucose within the animal may enter and exit the first chamber and the hydrocolloid solution changes in response to the presence or concentration of glucose within the first chamber. The sensing device also includes a reference chamber containing second magnetic particles and a reference solution wherein the second magnetic particles are dispersed in the reference solution. The reference solution (for example, oil or alcohol compounds) includes a known or fixed viscosity. The reference solution may also be a hydrocolloid solution (for example, ConA-dextran hydrocolloid).Type: GrantFiled: October 3, 2003Date of Patent: June 5, 2007Assignee: BioTex, Inc.Inventors: Ralph Ballerstadt, Roger McNichols, Ashok Gowda
-
Publication number: 20070122829Abstract: The present invention is directed to a system, device and method for measuring the concentration of an analyte in a fluid or matrix. A thermodynamically stabilized analyte binding ligand for use in the system, device and method is disclosed. The thermodynamically stabilized analyte binding ligand is resistant to degradation at physiological temperatures and its use within the device provides a minimally invasive sensor for monitoring the concentration of an analyte in a fluid or matrix as are present in the body of an animal.Type: ApplicationFiled: November 1, 2006Publication date: May 31, 2007Inventors: Ralph Ballerstadt, Roger McNichols, Ashok Gowda
-
Publication number: 20070117223Abstract: In one aspect, the present invention is a system, a device and a method for sensing the concentration of an analyte in a fluid or matrix. The analyte may be glucose or any other chemical of interest. The fluid or matrix may be, for example, the fluid in a bioreactor, a food or agricultural product, any fluid or matrix in the body of an animal, or any other fluid or matrix whose concentration of an analyte is under investigation. In one embodiment, the analyte sensing device includes a housing having an interior space. Contained within the housing and in the interior space is one or more analyte sensing component(s). The analyte sensing component, in one embodiment, includes one or more radiation converting element(s), for example, converting chromophores. The radiation converting element(s) are capable of converting or modifying radiation of one or more wavelengths into radiation of one or more different wavelengths.Type: ApplicationFiled: January 22, 2007Publication date: May 24, 2007Inventors: Ralph Ballerstadt, Roger McNichols, Ashok Gowda
-
Patent number: 7166458Abstract: In one aspect, the present invention is a system, a device and a method for sensing the concentration of an analyte in a fluid or matrix. The analyte may be glucose or any other chemical of interest. The fluid or matrix may be, for example, the fluid in a bioreactor, a food or agricultural product, any fluid or matrix in the body of an animal, or any other fluid or matrix whose concentration of an analyte is under investigation. In one embodiment, the analyte sensing device includes a housing having an interior space. Contained within the housing and in the interior space is one or more analyte sensing component(s). The analyte sensing component, in one embodiment, includes one or more radiation converting element(s), for example, converting chromophores. The radiation converting element(s) are capable of converting or modifying radiation of one or more wavelengths into radiation of one or more different wavelengths.Type: GrantFiled: December 12, 2003Date of Patent: January 23, 2007Assignee: Bio Tex, Inc.Inventors: Ralph Ballerstadt, Roger McNichols, Ashok Gowda
-
Publication number: 20060217693Abstract: In one embodiment, the disclosure is directed to an integrated apparatus for delivering energy to a tissue. The integrated apparatus included a housing having a distal end and a tubular structure located within the housing forming a first annulus between the tubular structure and the housing. The tubular structure is configured to accept an energy delivery component and is configured to form a second annulus between the tubular structure and the energy delivery component. The first annulus and the second annulus are configured to communicate with each other proximate to the distal end of the housing.Type: ApplicationFiled: November 7, 2003Publication date: September 28, 2006Inventors: Ashok Gowda, Roger McNichols, Marc Gelnett, Matthew Fox
-
Publication number: 20060104593Abstract: A light diffusing tip is provided. The light diffusing tip comprises a housing and a monolithic light scattering medium disposed within the housing. The monolithic light scattering medium comprises a first scattering region at a first position, the scattering region having a first scattering property and a second scattering region at a second position, the second scattering region having a second scattering property different from the first scattering property, wherein the first scattering region and the second scattering region are coextensive along a substantial portion of a length of the housing. A light diffusing applicator also is provided. The light diffusing applicator comprises at least one optical waveguide, a first termination coupled to a first end of the at least one optical waveguide, the first termination to couple to a light source and a light diffusing tip coupled to a second end of the at least one optical waveguide.Type: ApplicationFiled: November 16, 2004Publication date: May 18, 2006Inventors: Ashok Gowda, Roger McNichols, Marc Gelnett, Matthew Fox
-
Publication number: 20040132169Abstract: In one aspect, the present invention is a system, a device and a method for sensing the concentration of an analyte in a fluid or matrix. The analyte may be glucose or any other chemical of interest. The fluid or matrix may be, for example, the fluid in a bioreactor, a food or agricultural product, any fluid or matrix in the body of an animal, or any other fluid or matrix whose concentration of an analyte is under investigation. In one embodiment, the analyte sensing device includes a housing having an interior space. Contained within the housing and in the interior space is one or more analyte sensing component(s). The analyte sensing component, in one embodiment, includes one or more radiation converting element(s), for example, converting chromophores. The radiation converting element(s) are capable of converting or modifying radiation of one or more wavelengths into radiation of one or more different wavelengths.Type: ApplicationFiled: December 12, 2003Publication date: July 8, 2004Inventors: Ralph Ballerstadt, Roger McNichols, Ashok Gowda
-
Publication number: 20040073100Abstract: In one aspect, the present invention is directed to a glucose sensing device for implantation within subcutaneous tissue of an animal body. In one embodiment, the glucose sensing device includes a first chamber containing first magnetic particles and a hydrocolloid solution (for example, ConA-dextran hydrocolloid) wherein the first magnetic particles are dispersed in the hydrocolloid solution. In operation, glucose within the animal may enter and exit the first chamber and the hydrocolloid solution changes in response to the presence or concentration of glucose within the first chamber. The sensing device also includes a reference chamber containing second magnetic particles and a reference solution wherein the second magnetic particles are dispersed in the reference solution. The reference solution (for example, oil or alcohol compounds) includes a known or fixed viscosity.Type: ApplicationFiled: September 26, 2003Publication date: April 15, 2004Inventors: Ralph Ballerstadt, Roger McNichols, Ashok Gowda
-
Publication number: 20040072358Abstract: In one aspect, the present invention is directed to a glucose sensing device for implantation within subcutaneous tissue of an animal body. In one embodiment, the glucose sensing device includes a first chamber containing first magnetic particles and a hydrocolloid solution (for example, ConA-dextran hydrocolloid) wherein the first magnetic particles are dispersed in the hydrocolloid solution. In operation, glucose within the animal may enter and exit the first chamber and the hydrocolloid solution changes in response to the presence or concentration of glucose within the first chamber. The sensing device also includes a reference chamber containing second magnetic particles and a reference solution wherein the second magnetic particles are dispersed in the reference solution. The reference solution (for example, oil or alcohol compounds) includes a known or fixed viscosity. The reference solution may also be a hydrocolloid solution (for example, ConA-dextran hydrocolloid).Type: ApplicationFiled: October 3, 2003Publication date: April 15, 2004Inventors: Ralph Ballerstadt, Roger McNichols, Ashok Gowda
-
Publication number: 20030023236Abstract: The disclosures made herein relate to methods and equipment adapted for treatment of cardiac arrhythmias and for limiting, if not preventing, damage to surface tissue while coagulating tissue within the myocardium. In one embodiment of the disclosures made herein, a cooled tip laser catheter system includes an energy delivery apparatus, a laser apparatus and a cooling medium supply apparatus. The energy delivery apparatus includes a flexible tubular housing, a tip assembly and an optical waveguide. The flexible tubular housing includes a plurality of lumens therein extending between a proximal end and a distal end of the flexible tubular housing. The tip assembly includes a tip body attached at a first end thereof to the distal end of the flexible tubular housing and an optical window mounted at a second end of the tip body. The circulation chamber is defined within the tip body between the distal end of the flexible tubular housing and the optical window.Type: ApplicationFiled: July 30, 2002Publication date: January 30, 2003Applicant: Bio TexInventors: Ashok Gowda, Roger McNichols, Sohi Rastegar
-
Patent number: 6507747Abstract: An optical imaging probe for providing information representative of morphological arid biochemical properties of a sample is provided. The optical imaging probe includes a spectroscopic imaging probe element and an OCT imaging probe element.Type: GrantFiled: November 26, 1999Date of Patent: January 14, 2003Assignees: Board of Regents, The University of Texas System, BioTex, Inc.Inventors: Ashok Gowda, Roger McNichols, Massoud Motamedi
-
Publication number: 20020183604Abstract: A transcutaneous implant having a stable biological seal at the skin interface, obviating the need for puncturing the skin to obtain fluid samples is described. The implant includes an advanced filtration membrane to promote neovascularization which eliminates mass transfer problems by promoting the development of capillary networks with transcapillary mass transfer rates high enough to insure rapid exchange of analyte between blood and the device. Additionally the membrane provides a bioprotective layer which prevents transport of proteins and cellular components into the device.Type: ApplicationFiled: July 31, 2002Publication date: December 5, 2002Inventors: Ashok Gowda, Roger McNichols
-
Patent number: 6459917Abstract: A transcutaneous implant having a stable biological seal at the skin interface, obviating the need for puncturing the skin to obtain fluid samples is described. The implant includes an advanced filtration membrane to promote neovascularization which eliminates mass transfer problems by promoting the development of capillary networks with transcapillary mass transfer rates high enough to insure rapid exchange of analyte between blood and the device. Additionally the membrane provides a bioprotective layer which prevents transport of proteins and cellular components into the device.Type: GrantFiled: May 22, 2000Date of Patent: October 1, 2002Inventors: Ashok Gowda, Roger McNichols
-
Patent number: 6438397Abstract: A transcutaneous, implantable skin port sensor includes an access component and a sensor component, both of which can be made from inexpensive biocompatible materials. The access component provides a biological seal that forms around the skin port sensor. The sensor component facilitates non-invasive optically based measurement of analytes by providing a window to the body which avoids changes in the optical signal due to variations in skin optics, optical pathlength, ambient temperature and probe pressure. Tissue ingrowth or interstitial fluid in a through portion downstream of the optical window serves as the sample for the non-invasive, optically based measurement.Type: GrantFiled: October 28, 1999Date of Patent: August 20, 2002Inventors: Gerald G. Bosquet, Gerald L. Cote, Ashok Gowda, Roger McNichols, Sohi Rastegar
-
Publication number: 20020072657Abstract: A transcutaneous, implantable skin port sensor includes an access component and a sensor component, both of which can be made from inexpensive biocompatible materials. The access component provides a biological seal that forms around the skin port sensor. The sensor component facilitates non-invasive optically based measurement of analytes by providing a window to the body which avoids changes in the optical signal due to variations in skin optics, optical pathlength, ambient temperature and probe pressure. Tissue ingrowth or interstitial fluid in a through portion downstream of the optical window serves as the sample for the non-invasive, optically based measurement.Type: ApplicationFiled: October 28, 1999Publication date: June 13, 2002Inventors: GERALD G. BOUSQUET, GERALD L. COTE, ASHOK GOWDA, ROGER MCNICHOLS, SOHI RASTEGAR